The Europe radiotherapy patient positioning market is poised for substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 4.1% from 2022 to 2032. The market is anticipated to surpass USD 124.9 million in 2022, Europe radiotherapy patient positioning market is expected to reach USD 187.1 Million by the end of 2032, driven by factors such as increasing cancer diagnoses, demand for minimally invasive procedures, and improvements in healthcare infrastructure.
Radiotherapy stands as one of the primary treatment options for early-detected cancers, contributing significantly to the market’s expansion. In 2022, the markers segment held a substantial share of about 30.0% of Europe’s radiotherapy patient positioning market. This growth trend is expected to continue as the number of cancer cases rises, leading to a surge in mortality rates across various cancer stages.
Report Sample Comprehensive Insights: https://www.futuremarketinsights.com/reports/sample/rep-gb-14727
“As cancer diagnoses increase, so does the urgency for effective treatment options,” stated a FMI. “Radiotherapy plays a crucial role in early-stage cancer treatment, driving demand for advanced patient positioning solutions.”
The European healthcare sector’s commitment to enhancing infrastructure quality has further propelled market growth. Future Market Insights reports that the market is highly fragmented, with companies primarily headquartered in the Scandinavia region of Europe. The growing adoption of radiation therapy is predicted to further boost the radiotherapy patient positioning market in Europe.
The increasing prevalence of cancer underscores the importance of investing in advanced radiotherapy patient positioning solutions. Market players are expected to focus on innovation and strategic collaborations to capitalize on emerging opportunities in this rapidly evolving landscape.
Factors Restraining Demand for Europe Radiotherapy Patient Positioning Market:
- Alternative Therapies: The development of successful alternative cancer treatments, such as immunotherapy and breast lesion localization devices, reduces the reliance on radiotherapy altogether.
- Skilled Workforce Shortage: A lack of skilled professionals like radiologists, dosimetrists, and nurses who are crucial for administering radiotherapy treatment. This shortage makes it difficult to implement and expand radiotherapy procedures.
- Focus on Painless Techniques: The growing emphasis on painless and unique positioning techniques for radiotherapy might limit the market for traditional patient positioning equipment.
- Increased Use of Early-Stage Treatments: A rise in early-stage cancer treatments like surgery and chemotherapy, as seen in England, reduces the need for radiotherapy in some cases.
Request Customization of Report: https://www.futuremarketinsights.com/customization-available/rep-gb-14727
Competitive Landscape:
Key manufacturers are diligently pursuing the creation of innovative products tailored not only for radiation patient positioning but also for enhancing patient comfort. Consequently, the majority of these manufacturers are directing their efforts towards developing and gaining approval for novel products. Moreover, they are embracing merger and acquisition strategies to bolster their market presence.
- In March 2022, Elekta revealed a collaborative agreement with IBA aimed at optimizing quality assurance (QA) solutions. Additionally,
- In June 2020, Mevion Medical Systems and Orfit Industries announced that the Aerial® Couch Top had been validated for use on the MEVION S250 Series Proton Therapy Systems, marking a significant milestone.
Key Companies Profiled:
- Orfit Industries
- Qfix
- Elekta
- Eckert & Ziegler BEBIG
- CDR Systems
- Roper Technologies-CIVCO
- Best Medical Canada
- Blessing Cathay Corporation
- Candor ApS
- IZI Medical Products
- Klarity Medical Products
- MacroMedics BV
- OSL Oncology Systems Limited.
- T-Tape Company B.V.
Key Market Segments Covered in Radiotherapy Patient Positioning Industry Research:
By Product Type:
- Thermoplastic Masks & Sheets
- Head Masks
- Head & Shoulder Masks
- Torso & Extremities
- Markers
- Fiducial Markers
- Vaginal Markers
- Rectal Marker
- Immobilization System
- Head Rest
- Cushions
- Spacers & Wedges
- Arm & Wrist Support
- Locating & Indexing Bar
- Bite Positioners
By End User:
- Hospitals
- Cancer Research Institutes
- Radiation/Proton Therapy Centres
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
Request Purchase on Report: https://www.futuremarketinsights.com/checkout/14727
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
